Caris Life Sciences and National Cancer Center Japan Announce Exclusive Collaboration to Launch The SCRUM-Japan MONSTAR-SCREEN-2 Trial

IRVING, Texas: IRVING, Texas, May 20, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today they have entered into an exclusive collaboration agreement with the National Cancer Center Japan (NCC) to provide Caris' comprehensive...

Click to view original post